GlobeNewswire

2024-06-20 19:00

Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia

NEW YORK and SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, thereby transforming healthcare, today announced the launch of Broken Coast EU-GMP certified medical cannabis products in Australia.

Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, “Our highly scalable global footprint, which enables us to deliver medical cannabis globally from our facilities in Canada as well as our facilities in Europe, combined with our diverse portfolio of cannabis brands and products have been instrumental in leading the evolution of the global medical cannabis industry. As medical cannabis demand continues to grow worldwide, Tilray Brands remains steadfast in our commitment to providing healthcare professionals and patients with safe and reliable access to the highest-quality medical cannabis products.

Ms. Faltischek continued, “We have been vigilant in ensuring that we continue to fulfill our mission of transforming the lives of patients by empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions. The launch of Broken Coast medical cannabis in response to the feedback we received in Australia and leveraging insights from our operations in Canada and Europe, further evidences our commitment to our mission. Our unwavering dedication to innovation, quality and patient needs continues to be the foundation upon which we build our success and growth.”

Medical Cannabis patients in Australia now have access to Broken Coast’s renowned cannabis strains cultivated by Broken Coast and manufactured by Avanti Rx Analytics Inc. (Avanti RX), Tilray Brands’s EU-GMP certified facility located in Canada, which also holds a Health Canada Drug Establishment License, ensuring the highest quality and safety standards for medical cannabis patients and consumers.

The following Broken Coast products are now available for medical cannabis patients in Australia:

  1. Broken Coast Amnesia Haze THC22 10g
  2. Broken Coast OG Kush Breath THC25 10g
  3. Broken Coast Cherry Cheesecake THC19 10g
  4. Broken Coast EmergenZ THC27 10g – Expected availability in July 2024

Tilray continues to be one of the leading providers of EU-GMP certified medical cannabis to patients, physicians, pharmacies, hospitals, governments, and researchers across the globe, and today is a leading provider of EU-GMP certified medical cannabis products in over 20 countries with a comprehensive portfolio of THC and CBD products. In furtherance of its mission, Tilray has supported medical trials globally studying the efficacy of medical cannabis as a treatment for indications including pediatric epilepsy, refractory pediatric epilepsy, cancer-induced nausea and vomiting, HIV, essential tremor, breast cancer disorders, post-traumatic stress disorder, and alcohol use disorders.

About Tilray Medical
Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios and Navcora. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first EU-GMP certified cannabis production facilities in Europe, specifically in Portugal and Germany simultaneously. Today, Tilray Medical is one of the largest suppliers of medical cannabis to patients, physicians, hospitals, pharmacies, researchers, and governments in 20 countries and across five continents.

For more information on Tilray Medical, visit Tilray Medical Europe, Tilray Medical Canada, and Tilray Medical Australia-New Zealand.

About Tilray Brands 

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilray’s mission is to be the most responsible, trusted and market leading cannabis consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.  

For more information on Tilray Brands visit, Tilray.com and follow @Tilray on all social platforms. 

Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For further information, please contact:

Tilray Brands Media: news@tilray.com  
Investors: investors@tilray.com  


Primary Logo

source: Tilray Brands, Inc.

【你點睇?】陳智思認為應制訂指標,衡量來港人才能否直接幫助本地經濟等。你是否認同?► 立即投票

人氣文章
最近7天
1
高息定存 | 滙豐一周港元定存年息高達10厘,招商永隆推快閃優惠
2
港股 | 蕭猷華:恒指本周料挑戰25000大關
3
高息定存 | 一周高息合集,華僑6個月最高3.5厘,恒生7日享10厘
4
四叔辭世 | 恒地李兆基辭世享年97歲,創立地產王國被封「亞洲股神」,交捧兩子分管中港業務(圖集)
5
美團上季經調整盈利升逾倍,加大對AI、無人機配送等投入,Keeta沙特用戶訂單迅速增長
6
騰訊業績 | 騰訊全年多賺近七成,縮回購增派息,今年續加大AI投入
7
2025年美股市場將更波動    板塊輪動進一步加劇
8
小米 | 小米上季經調整盈利增69%遠勝預期,雷軍:今年交付目標提升至35萬輛
9
比亞迪發布超級e平台,閃充5分鐘續航470公里,開啟油電同速
10
David Webb預告逝世後續開放資料庫,惟不具備編輯功能
1
財政預算案2025 | 重點文字直播/Youtube直播(稍後送上懶人包)
2
高息定存 | 一周高息合集,3個月5厘之選有邊間?6個月最高3.55厘
3
2025強積金整合獎賞一覽 轉供應商最多竟然可賺!?
4
比特幣 | 亞洲時段虛擬貨幣大幅下跌,31萬人爆倉
5
美股收盤 | 美股三大指數收市報跌,道指跌近750點
6
港股 | 蕭猷華:恒指上半年目標25000點
7
高息定存 | 銀行加港元存息,東亞3個月加至3.5厘10萬起存
8
財政預算案 | 唐英年:發債當「收入」是「假盈餘」,但非不負責任
9
「數碼轉型支援先導計劃」成效顯著 提升中小企生意額
10
美股收盤 | 美股三大指數收市報升,道指反彈674點
11
預算案 | 財政預算案2025懶人包
12
美股收盤 | 美股三大指數收市報升,道指升逾600點
13
財政預算案 | 「兩元兩折」最遲明年9月推,孫玉菡:八達通更改需時
14
專訪 | 花旗劉顯達:恒指後勢還待業績期 點名七大長線首選個股
15
高息定存 | 一周高息合集,工銀亞洲低門檻3個月5厘,Mox推1個月10厘
16
BTC | 15億美元以太幣被盜,恐為史上金額最大虛擬貨幣竊案
17
高息定存 | 工銀亞洲3個月3.68厘起存150萬,低門檻最高5厘
18
高息定存 | 一周高息合集,大行推6個月3.5厘,一年期最高3.55厘
19
高息定存 | PAObank1個月高達8厘,招商永隆推快閃優惠
20
巴拿馬運河 | 長和擬售非中國港口資產套現逾190億美元,強調屬純商業決定
21
【FOCUS】阿里撥「雲」見日,押注「計算」基建前景
22
高息定存 | 恒生一周港元定存年息高達10厘,1個月4.5厘
23
預算案|兩小時宣讀眾生相,有議員查看阿里期權報價,葉劉戴墨鏡出席(圖集)
24
神州經脈 | 外貿弱開局,外儲黃金儲備同增,滬指周升逾1%
25
巴拿馬運河 | 英國金融時報:李嘉誠及李澤鉅主理長和世紀交易,談判數周即落槌
26
【FOCUS】「投資禁令」狼又來,真狠辣劍指合規及課稅
27
專訪 | 洪灝:形勢比想象嚴峻,炒作DS如淘金賣鏟子先賺錢(有片)
28
阿里季績勝預期大行齊唱好,股價飆逾14%是否未見頂?
29
港股 | 午市前瞻 | 300億北水大軍力抗環球震盪 守穩一指標至關重要
30
電話詐騙 | 王毅:臨近邊境的緬北電詐園區已全部清除
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

etnet榮膺「第九屆傳媒轉型大獎」四大獎項

【限時優惠$68/月】申請etnet強化版MQ手機串流報價服務 捕捉板塊輪動,提高獲利勝算

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老